Novoron Bioscience , Inc. logo

Novoron Bioscience , Inc.

Novoron develops therapeutics for conditions related to damaged CNS. Novoron Bioscience is a biotechnology company focused on advancing a pipeline of biologic therapeutics for spinal cord injury, multiple sclerosis and glaucoma and is part of the JLABS innovation community.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttps://www.novoron.com
Founded2013
Disease Focus
Development Stage
STOCK CODENon Listed
Address
7770 Regents Rd #113319, CA, 92122
San Diego
United States
Email
Contact Number

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/novoron-bioscience” connections=”true” suffix=””]

In Dec 2015, Novoron received $680,000 NIH SBIR grant to expand its preclinical work to evaluate new treatments for Multiple Sclerosis Also in past, has received five more NIH grants, totaling more than $1.2 Mn for neurological disorders.